TFCP2 Genetic Polymorphism Is Associated with Predisposition to and Transplant Prognosis of Hepatocellular Carcinoma

Table 1

Clinical data for the non-HCC and HCC groups.

Variable	Non-HCC; ()	HCC; ()	value
Age (years), n (%)			0.155
≤50	128 (64)	66 (56)
>50	72 (36)	53 (44)
Gender			0.008
Male, n (%)	163 (82)	110 (92)
Female, n (%)	37 (19)	9 (8)
BMI (kg/m^2)	23.2 ± 6.4	24.2 ± 8.5	0.299
Etiology of liver diseases, n (%)			0.164
HBV	151 (76)	98 (82)
Others	49 (24)	21 (18)
Child score	9.5 ± 2.1	7.5 ± 2.1	<0.001
MELD score	21.2 ± 11.8	12.1 ± 5.7	<0.001

BMI, body mass index; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; MELD, model for end-stage liver disease. The data were presented as mean ± SD. Values in italics indicate significance.